Month: March 2018

Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients

VANCOUVER, British Columbia, March 05, 2018 — Lexington Biosciences, Inc. (CSE:LNB) (LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to provide an early update of its clinical trial and patient enrollment. As previously announced, the Company’s HeartSentry device is undergoing clinical studies designed to measure the safety and effectiveness of the

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News